bioMerieux, Inc. VIDAS Estradiol II, REF 30431-01 Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
VIDAS Estradiol II, REF 30431-01
Brand
bioMerieux, Inc.
Lot Codes / Batch Numbers
UDI 03573026161637, Lot #: 1008757880
Products Sold
UDI 03573026161637, Lot #: 1008757880
bioMerieux, Inc. is recalling VIDAS Estradiol II, REF 30431-01 due to bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore lea. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
bioMerieux has been receiving an increasing number of complaints linked to a VIDAS substrate error. It prevents the test from being run, therefore leads to potential delayed results as the user must run another test.
Recommended Action
Per FDA guidance
For products with No remaining shelf life (taking into account the revised expiration date): - Identify impacted lots - Stop using the listed impacted lots - Destroy the remaining impacted lots in your inventory For products with remaining shelf life (taking into account the revised expiration date): - Identify impacted products and lots listed - Update product expiration date per your internal procedures of the remaining usable lots to meet the new revised expiration date specified in Table 1 - Continue product use until the revised expiration date. Consignees are asked to distribute this information to all appropriate personnel in their laboratory, retain a copy in their files, and forward this information to all parties that may use this product, including others to whom you may have transferred affected product. Complete the Acknowledgement Form in Attachment A and return it to USFieldActions@biomerieux.com or Fax to: (919) 620-3306 to confirm receipt of this notice.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026